/ No need to treat Isolated mild/moderate thrombocytopenia : Study - Speciality Medical Dialogues
This site is intended for Healthcare professionals only.

No need to treat Isolated mild/moderate thrombocytopenia : Study


No need to treat Isolated mild/moderate thrombocytopenia : Study

Pediatric patients with isolated mild or moderate thrombocytopenia(TP) may not need a specialist referral to hematology in most circumstances, according to a study published in the journal Pediatrics. The majority of patients with mild or moderate TP normalized platelet counts within 3 months. Mild isolated thrombocytopenia without a bleeding history or abnormal physical findings did not require interventions from pediatric hematology-oncology whereas moderate isolated TP cases rarely required interventions.

Isolated thrombocytopenia is a common pediatric laboratory finding among patients with a bleeding or bruising history as well as being an incidental laboratory finding. Pediatric patients with congenital or acquired viral infections may develop TP because of alterations in platelet production or platelet destruction.

Charles Schlappi and his associates conducted a study to test the hypothesis that patients with isolated asymptomatic mild TP would not progress to require an intervention from a pediatric hematologist-oncologist.

The study included  113 patients referred to pediatric hematology-oncology for isolated thrombocytopenia which continued for  5 years. Initial, lowest, and current platelet counts along with clinical course and need for interventions were recorded. TP was categorized as mild (platelet count: 101–140 × 103/μL), moderate (platelet count: 51–100 × 103/μL), severe (platelet count: 21–50 × 103/μL), and very severe (platelet count: ≤20 × 103/μL).

Key findings :

  • Eight of 48 patients (17%) referred for initial mild isolated thrombocytopenia progressed to moderate TP at 1 visit.
  • At present, 2 of these patients have moderate thrombocytopenia, 17 remain with mild TP, and 29 patients have resolved thrombocytopenia.
  • Nine of 65 patients (14%) referred for moderate TP progressed to severe or very severe TP on 1 occasion.
  • At present, no patients have severe thrombocytopenia, 18 remain with moderate TP, 14 improved to mild TP, and 33 have resolved thrombocytopenia.
  • Only 3 patients required interventions from a hematologist, whereas 10 patients required therapy from other subspecialties.

The study concluded that only 3 identified patients (3%) with mild to moderate TP required an intervention from a hematologist to improve platelet counts. Patients with isolated mild TP with a normal bleeding history and physical examination findings frequently have normalized their platelet counts within 1 month.

For more information log on to

http://pediatrics.aappublications.org/content/early/2018/06/07/peds.2017-3804


Source: With inputs from the journal Pediatrics

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted